Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLGL Sol-Gel Technologies

Trading 04-01 10:47:58 EDT

81.09

+1.87

+2.36%

High81.09	Low81.09	Vol4.01K
Open81.09	D1 Closing79.22	Amplitude0.00%
Mkt Cap265.08M	Tradable Cap57.51M	Total Shares3.27M
T/O322.74K	T/O Rate0.57%	Tradable Shares709.20K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLGL","market":"US","secType":"STK","nameCN":"Sol-Gel Technologies","latestPrice":81.09,"timestamp":1775054875284,"preClose":79.22,"halted":0,"volume":4012,"delay":0,"changeRate":0.023605150214592332,"floatShares":709200,"shares":3269000,"eps":-2.199309,"marketStatus":"Trading","change":1.87,"latestTime":"04-01 10:47:58 EDT","open":81.09,"high":81.09,"low":81.09,"amount":322740.24476000003,"amplitude":0,"askPrice":85,"askSize":6,"bidPrice":78.99,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.199309,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1775073600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1517461200000,"exchange":"NASDAQ","adjPreClose":79.22,"preHourTrading":{"tag":"盘前","latestPrice":80.8,"preClose":79.22,"latestTime":"08:33 EDT","volume":1,"amount":80.8,"timestamp":1775046788718,"change":1.58,"changeRate":0.019944,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":79.22,"preClose":79.22,"latestTime":"16:10 EDT","volume":8,"amount":641.04,"timestamp":1774987805022,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.317339,"impliedVol":1.504,"impliedVolPercentile":0.9565},"requestUrl":"/m/hq/s/SLGL","defaultTab":"news","newsList":[{"id":"2622015737","title":"Sol-Gel Highlights Phase 3 Development of SGT-610 for Gorlin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2622015737","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622015737?lang=en_us&edition=fundamental","pubTime":"2026-03-25 05:15","pubTimestamp":1774386921,"startTime":"0","endTime":"0","summary":"Sol-Gel said it is developing SGT-610 as a potential treatment for Gorlin syndrome, targeting a rare-disease market with limited approved options. The company said the program has drawn physician interest that could support expansion into high-frequency basal cell carcinoma, which could broaden its commercial opportunity. Sol-Gel estimated peak annual net sales potential for SGT-610 of more than USD 600 million if approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLc7sjKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622791018","title":"Opaleye Management acquired USD 2,855,880 of Sol-Gel Technologies common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622791018","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622791018?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:07","pubTimestamp":1774382837,"startTime":"0","endTime":"0","summary":"Opaleye Management, a 10% owner of Sol-Gel Technologies, reported purchases of ordinary shares at USD 72 per share.Opaleye, L.P. acquired 34,665 shares, bringing its reported holdings to 485,000 shares.A separately managed account acquired 5,000 shares, bringing its reported holdings to 15,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL16pyp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management acquired USD 2,855,880 of Sol-Gel Technologies common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622561097","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2622561097","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622561097?lang=en_us&edition=fundamental","pubTime":"2026-03-25 02:20","pubTimestamp":1774376403,"startTime":"0","endTime":"0","summary":"CVD Equipment  said Tuesday it has agreed to sell its Stainless Design Concepts unit to Atlas Copco Group for about $16.9 million in cash.Shares rose roughly 37% as midday trading volume rose to over 9.5 million shares from a daily average of roughly 70,000.Sol-Gel Technologies  shares were up about 28%, a day after the firm priced an oversubscribed underwritten offering of 459,112 shares at $72.00 a share.Intraday trading volume stood at more than 47,000 shares, against a daily average of about 27,000.Merlin  said it was named to Fast Company's list of the World's Most Innovative Companies.Shares rose 24%, with trading volume of around 2.6 million.Price: 5.14, Change: +1.41, Percent Change: +37.67","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MRLN","BK4164","CVV.AU","BK4007","SLGL","BK4147","CVV","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621069667","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069667","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069667?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:16","pubTimestamp":1774350967,"startTime":"0","endTime":"0","summary":"Netgear  shares were 12% higher pre-bell Tuesday after the Federal Communications Commission banned the import of all new foreign-made consumer routers.Jefferies Financial  stock was up 8% following a Financial Times report that Sumitomo Mitsui Financial Group  is considering acquiring the US-based investment bank.Sol-Gel Technologies  shares were 7% higher, a day after the company said it has priced an oversubscribed underwritten offering of ordinary shares for gross proceeds of about $33.1 million.Acurx Pharmaceuticals  stock was up 6%, reversing from Monday's slide.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4127","ACXP","BK4207","BK4539","BK4139","BK4559","BK4020","BK4563","JEF","BK4007","SLGL","SMFG","NTGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621030645","title":"Sol-Gel Technologies 459K share Spot Secondary priced at $72.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2621030645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621030645?lang=en_us&edition=fundamental","pubTime":"2026-03-24 12:10","pubTimestamp":1774325424,"startTime":"0","endTime":"0","summary":"TD Cowen and LifeSci Capital are acting as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sol-gel-technologies-459k-share-spot-secondary-priced-at-72-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sol-gel-technologies-459k-share-spot-secondary-priced-at-72-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621039733","title":"Press Release: Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2621039733","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621039733?lang=en_us&edition=fundamental","pubTime":"2026-03-24 09:38","pubTimestamp":1774316280,"startTime":"0","endTime":"0","summary":"NESS ZIONA, Israel, March 23, 2026  -- Sol-Gel Technologies Ltd.   today announced the pricing of an underwritten offering of 459,112 ordinary shares  at a price of $72.00 per Share, resulting in gross proceeds to the Company, before deducting underwriting discounts and commissions and other estimated offering expenses, of approximately $33.1 million. All of the Shares are to be sold by the Company. The offering is expected to close on or about March 25, 2026, subject to satisfaction of customary closing conditions.The Company intends to use the net proceeds from the offering to fund the continued development of SGT-610, including pre-commercialization activities and research and development, and the remainder for working capital and other general corporate purposes.TD Cowen and LifeSci Capital are acting as joint book-running managers for the offering.Sol-Gel is a specialized dermatology company advancing innovative therapies for rare and serious skin diseases. Its lead investigationa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","BCC","BK4232","BK4022","BK4567","BK4104","R","SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620206736","title":"Sol Gel Technologies Ltd  expected to post a loss of $1.84 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620206736","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620206736?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:55","pubTimestamp":1774011304,"startTime":"0","endTime":"0","summary":"Sol Gel Technologies Ltd  expected to post a loss of $1.84 a share - Earnings Preview Sol Gel Technologies Ltd SLGL.OQ SLGL.O is expected to  show a fall in quarterly revenue when it reports  results ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N408188:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620099228","title":"Sol-Gel FY 2025 net loss narrows 42.08% to USD 6.13 million on revenue up 68.06% to USD 19.39 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620099228","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620099228?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:53","pubTimestamp":1773924836,"startTime":"0","endTime":"0","summary":"Sol-Gel published its annual report on Form 20-F for the year ended Dec. 31, 2025.Revenue rose 68.05% to USD 19.39 million, mainly from milestone payments tied to the Mayne and Searchlight agreements.Net loss narrowed 42.09% to USD 6.13 million, while R&D expense increased 28.1% to USD 22.8 million.Cash and cash equivalents, bank deposits and marketable securities were USD 12.4 million as of Dec. 31, 2025, and management said this is expected to fund operations into the first quarter of 2027.Enrollment was completed in August 2025 in Sol-Gel’s Phase 3 SGT-610  trial in Gorlin syndrome, with topline results expected in the fourth quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the orig","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL1F4ZYt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620822577","title":"Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2620822577","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620822577?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:53","pubTimestamp":1773924780,"startTime":"0","endTime":"0","summary":"NESS ZIONA, Israel, March  19, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd.(NASDAQ: SLGL), announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3259020/0/en/Sol-Gel-Files-Annual-Report-on-Form-20-F-for-the-Year-Ended-December-31-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCC","BK4104","BK4007","SLGL","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620261562","title":"Sol-Gel Technologies Ltd. CFO Eyal Ben-Or files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620261562","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620261562?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:13","pubTimestamp":1773861214,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership by Eyal Ben-Or, its chief financial officer. Ben-Or reported direct beneficial ownership of 1,000 ordinary shares. He also reported stock options covering 2,500 ordinary shares at an exercise price of USD 8.34. Ben-Or also reported stock options covering 4,055 ordinary shares at an exercise price of USD 8.96.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4Xpgwy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620269056","title":"Sol-Gel Technologies director Sharon Kochan files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620269056","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620269056?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:01","pubTimestamp":1773860501,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership by director Sharon Kochan. Kochan reported a direct stock option covering 7,500 ordinary shares. The option has an exercise price of USD 12 and an expiration date of Jan. 9, 2034.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLb11dBw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620269200","title":"Sol-Gel Technologies Ltd. director Yanai Yuval files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620269200","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620269200?lang=en_us&edition=fundamental","pubTime":"2026-03-19 02:56","pubTimestamp":1773860198,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership for director Yuval Yanai. The filing listed a stock option for 7,500 ordinary shares with an exercise price of USD 12. The option has an expiration date of 01/09/2034.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9GPPrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620268439","title":"Sol-Gel Technologies names Chief Business Officer Michael Glezin in initial beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620268439","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620268439?lang=en_us&edition=fundamental","pubTime":"2026-03-19 00:21","pubTimestamp":1773850872,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership for Michael Glezin, its chief business officer. The filing reported 1,500 ordinary shares held directly. It also reported stock options for 2,500 ordinary shares with an exercise price of USD 50. Additional stock options covered 5,000 ordinary shares with an exercise price of USD 9.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3K7Sj0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620268974","title":"Sol-Gel Technologies names Ofra Levy-Hacham as VP Clinical, Reg & Quality in Form 3 beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620268974","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620268974?lang=en_us&edition=fundamental","pubTime":"2026-03-19 00:18","pubTimestamp":1773850731,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership for Ofra Levy-Hacham, an officer serving as VP Clinical, Reg and Quality. The filing lists stock options for 569 ordinary shares with an exercise price of USD 15.89 and an expiration date of 08/01/2026. It also lists stock options for 6,092 ordinary shares with an exercise price of USD 100 and an expiration date of 03/29/2032. The statement was signed by Eyal Ben-Or as attorney-in-fact.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL13DyCk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620268942","title":"Sol-Gel Technologies files Form 3 initial beneficial ownership statement for VP Research & Dev Ofer Toledano","url":"https://stock-news.laohu8.com/highlight/detail?id=2620268942","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620268942?lang=en_us&edition=fundamental","pubTime":"2026-03-19 00:16","pubTimestamp":1773850566,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership for Ofer Toledano, Vice President of Research and Development. Toledano reported direct beneficial ownership of 1,461 ordinary shares. He also reported stock options covering 22,274 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9SpwWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620268601","title":"Sol-Gel Technologies Chairman and CEO Moshe Arkin files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620268601","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620268601?lang=en_us&edition=fundamental","pubTime":"2026-03-19 00:13","pubTimestamp":1773850403,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies reported an initial statement of beneficial ownership for Moshe Arkin, who is chairman of the board and CEO. The filing also lists him as a director and a 10% owner. Arkin reported direct beneficial ownership of 143,257 ordinary shares. He also reported indirect beneficial ownership of 1.61 million ordinary shares held through M. Arkin Dermatology. The filing lists warrants for 200,000 ordinary shares with an exercise price of USD 58.5, held indirectly through M. Arkin Dermatology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLcdGBcB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618211536","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:38 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2618211536","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618211536?lang=en_us&edition=fundamental","pubTime":"2026-03-09 21:38","pubTimestamp":1773063503,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:38 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nAQN2LPC61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612724475","title":"Major Investor Quietly Boosts Its Stake in Sol-Gel Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2612724475","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612724475?lang=en_us&edition=fundamental","pubTime":"2026-02-19 10:06","pubTimestamp":1771466800,"startTime":"0","endTime":"0","summary":"New insider activity at Sol-Gel Technologies ( ($SLGL) ) has taken place on February 18, 2026. Opaleye Management Inc., a significant shareholder i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-its-stake-in-sol-gel-technologies-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-its-stake-in-sol-gel-technologies-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612426052","title":"Opaleye Management Inc. reports acquisition of Sol-Gel Technologies common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612426052","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612426052?lang=en_us&edition=fundamental","pubTime":"2026-02-19 05:06","pubTimestamp":1771448775,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. reported an acquisition of common shares of Sol-Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL4l9qml:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Opaleye Management Inc. reports acquisition of Sol-Gel Technologies common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607305911","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2607305911","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607305911?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:17","pubTimestamp":1769721429,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc. reported an acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL1cPqpC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sol-gel.com;ir.sol-gel.com","stockEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":-0.1359},{"period":"3month","weight":0.8799},{"period":"6month","weight":1.6854},{"period":"1year","weight":14.2346},{"period":"ytd","weight":0.8799}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.052},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0282},{"period":"1year","weight":0.1626},{"period":"ytd","weight":-0.0463}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.051839},{"month":2,"riseRate":0.375,"avgChangeRate":-0.014217},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.064913},{"month":4,"riseRate":0.375,"avgChangeRate":0.000899},{"month":5,"riseRate":0.5,"avgChangeRate":0.013217},{"month":6,"riseRate":0.625,"avgChangeRate":-0.011897},{"month":7,"riseRate":0.5,"avgChangeRate":0.06768},{"month":8,"riseRate":0.5,"avgChangeRate":0.113954},{"month":9,"riseRate":0.5,"avgChangeRate":-0.011791},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064677},{"month":11,"riseRate":0.625,"avgChangeRate":0.040189},{"month":12,"riseRate":0.375,"avgChangeRate":0.187906}],"exchange":"NASDAQ","name":"Sol-Gel Technologies","nameEN":"Sol-Gel Technologies"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sol-Gel Technologies,SLGL,Sol-Gel Technologies股票,Sol-Gel Technologies股票老虎,Sol-Gel Technologies股票老虎国际,Sol-Gel Technologies行情,Sol-Gel Technologies股票行情,Sol-Gel Technologies股价,Sol-Gel Technologies股市,Sol-Gel Technologies股票价格,Sol-Gel Technologies股票交易,Sol-Gel Technologies股票购买,Sol-Gel Technologies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction